Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 38 (4) , 419-425
- https://doi.org/10.1016/s0168-8278(02)00442-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot studyJournal of Hepatology, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitisJournal of Hepatology, 2001
- Cytokines in Alcoholic Liver DiseaseSeminars in Liver Disease, 1999
- Tumor Necrosis Factor and Alcoholic Liver DiseaseAlcohol, Clinical and Experimental Research, 1998
- Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient MiceScience, 1996
- Cytokine levels in acute alcoholic hepatitis: a sequential studyDrug and Alcohol Dependence, 1995
- Increased plasma interleukin-8 concentrations in alcoholic hepatitisHepatology, 1993
- Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patientsHepatology, 1991
- Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic HepatitisAlcohol, Clinical and Experimental Research, 1990